Storgate’s Labcorp LH Stock Holding History

Storgate’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.97M	Buy	7,025 +4,204	+149%	+$1.11M	0.41%	41
2026 Q1	$753K	Buy	2,821 +111	+4%	+$30.1K	0.59%	29
2025 Q4	$680K	Buy	+2,710	New	+$720K	0.56%	37

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Storgate's LH Position: Q2 2026 in Review

Storgate increased its Labcorp (LH) stake by 149% in Q2 2026, buying an estimated $1.11M and bringing the position to 7,025 shares worth $1.97M. The position accounts for 0.41% of the portfolio, ranked #41.

Storgate first reported a position in LH in Q4 2025 and has held it in 3 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Storgate held 7,025 shares of Labcorp worth $1.97M as of Q2 2026.
Storgate bought 4,204 Labcorp shares in Q2 2026, an estimated $1.11M.
Labcorp made up 0.41% of Storgate's portfolio in Q2 2026, its #41 holding.
Storgate first reported a position in Labcorp in Q4 2025 and has held it in 3 quarters since.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Storgate's 13F filing for Q2 2026, filed 12 Aug 2026.